Received: 28 June 2021
Accepted: 20 September 2021
First Online: 1 October 2021
: Ethics approval was obtained from the Human Research Ethics Committee from each participating country: Australia (Federation University Australia, Ref: B20-036), Bangladesh (Enam Medical College, Ref: EMC/ERC/2020/08-2), Egypt (Ain Shams University, Ref: FMASU R 121/2020), Hong Kong (The Chinese University of Hong Kong, Ref: SBRE-20-172), Indonesia (Universitas Indonesia, Ref: KET-1425/UN2.F1/ETIK/PPN.00.02/2020), Jordan (The Hashemite University), Kuwait (Kuwait University, Ref: VDR/EC/3693), Libya (Al-Brega General Hospital), Malaysia (Universitas Sains Malaysia, Ref: USM/JEPeM/COVID19-40), Nepal (Kathmandu Medical College Public Ltd., Ref: 2611202004), Oman (Ministry of Health, Ref: MoH/CSR/20/24012), Pakistan (Lahore Garrison University), Saudi Arabia (Ministry of Health, Ref: 20-605E), Syria (University of Aleppo), Thailand (Chiang Mai University, Ref: AF 04-021), United Arab Emirates (Abu Dhabi University, Ref: CoHS-20-20-00024). Each study participant read the consent form along with plain language summary and ticked their consent in the online form prior to accessing the study questionnaire.
: Data were collected anonymously, therefore, no identifying information were collected from the study participants.
: The authors confirm that there are no known conflicts of interest associated with this publication.